Pring Turner Capital Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-29,343
Closed -$1.73M 72
2024
Q2
$1.73M Sell
29,343
-3,269
-10% -$204K 1.21% 30
2024
Q1
$2.6M Sell
32,612
-526
-2% -$40.2K 1.9% 23
2023
Q4
$2.62M Sell
33,138
-534
-2% -$38K 2% 23
2023
Q3
$2.35M Sell
33,672
-2,667
-7% -$189K 1.97% 23
2023
Q2
$2.51M Sell
36,339
-481
-1% -$34.2K 2.3% 21
2023
Q1
$2.74M Buy
36,820
+100
+0.3% +$8.39K 2.72% 20
2022
Q4
$3.42M Sell
36,720
-2,230
-6% -$215K 3.73% 8
2022
Q3
$3.71M Sell
38,950
-20,005
-34% -$1.98M 3.74% 6
2022
Q2
$5.46M Sell
58,955
-370
-0.6% -$36.1K 5.24% 2
2022
Q1
$6M Buy
59,325
+1,250
+2% +$131K 4.63% 2
2021
Q4
$5.99M Buy
+58,075
New +$5.37M 5.3% 1
2018
Q4
$2.85M Sell
43,475
-210
-0.5% -$15.7K 4.02% 6
2018
Q3
$3.44M Buy
43,685
+740
+2% +$52.9K 4.41% 4
2018
Q2
$2.76M Buy
42,945
+150
+0.4% +$9.88K 2.92% 15
2018
Q1
$2.66M Buy
42,795
+10,445
+32% +$749K 2.77% 18
2017
Q4
$2.35M Sell
32,350
-300
-0.9% -$21.8K 2.53% 22
2017
Q3
$2.65M Sell
32,650
-770
-2% -$60.9K 2.63% 19
2017
Q2
$2.69M Buy
+33,420
New +$2.64M 2.73% 19

Other funds holding CVS

Pring Turner Capital Group's CVS Position: Q3 2024 in Review

Pring Turner Capital Group sold out of CVS Health (CVS) in Q3 2024, closing a stake of 29,343 shares — an estimated $1.73M sold.

Pring Turner Capital Group first reported a position in CVS in Q2 2017 and held it in 18 quarters. The position peaked at $6M in Q1 2022. 1,841 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Pring Turner Capital Group reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Pring Turner Capital Group sold 29,343 CVS Health shares in Q3 2024, an estimated $1.73M.
  • Pring Turner Capital Group first reported a position in CVS Health in Q2 2017 and held it in 18 quarters.
  • Pring Turner Capital Group's CVS Health position peaked at $6M in Q1 2022.
  • 1,841 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Pring Turner Capital Group's 13F filing for Q3 2024, filed 13 Nov 2024.